Pippin JW - Search Results

1

Inducible rodent models of acquired podocyte diseases.

Pippin JW, Brinkkoetter PT, Cormack-Aboud FC, Durvasula RV, Hauser PV, Kowalewska J, Krofft RD, Logar CM, Marshall CB, Ohse T, Shankland SJ. Pippin JW, et al. Am J Physiol Renal Physiol. 2009 Feb;296(2):F213-29. doi: 10.1152/ajprenal.90421.2008. Epub 2008 Sep 10. Am J Physiol Renal Physiol. 2009. PMID: 18784259 Free article. Review.

2

Role of leukocytes in metabolic and functional derangements of experimental glomerulonephritis.

Lefkowith JB, Nagamatsu T, Pippin J, Schreiner GF. Lefkowith JB, et al. Am J Physiol. 1991 Aug;261(2 Pt 2):F213-20. doi: 10.1152/ajprenal.1991.261.2.F213. Am J Physiol. 1991. PMID: 1877646

3

Tubulointerstitial disease in glomerulonephritis. Potential role of osteopontin (uropontin).

Pichler R, Giachelli CM, Lombardi D, Pippin J, Gordon K, Alpers CE, Schwartz SM, Johnson RJ. Pichler R, et al. Am J Pathol. 1994 May;144(5):915-26. Am J Pathol. 1994. PMID: 8178943 Free PMC article.

4

Differential expression of transforming growth factor-beta isoforms and receptors in experimental membranous nephropathy.

Shankland SJ, Pippin J, Pichler RH, Gordon KL, Friedman S, Gold LI, Johnson RJ, Couser WG. Shankland SJ, et al. Kidney Int. 1996 Jul;50(1):116-24. doi: 10.1038/ki.1996.294. Kidney Int. 1996. PMID: 8807580 Free article.

5

Changes in cell-cycle protein expression during experimental mesangial proliferative glomerulonephritis.

Shankland SJ, Hugo C, Coats SR, Nangaku M, Pichler RH, Gordon KL, Pippin J, Roberts JM, Couser WG, Johnson RJ. Shankland SJ, et al. Kidney Int. 1996 Oct;50(4):1230-9. doi: 10.1038/ki.1996.432. Kidney Int. 1996. PMID: 8887282 Free article.

6

Mesangial cell proliferation mediated by PDGF and bFGF is determined by levels of the cyclin kinase inhibitor p27Kip1.

Shankland SJ, Pippin J, Flanagan M, Coats SR, Nangaku M, Gordon KL, Roberts JM, Couser WG, Johnson RJ. Shankland SJ, et al. Kidney Int. 1997 Apr;51(4):1088-99. doi: 10.1038/ki.1997.151. Kidney Int. 1997. PMID: 9083274 Free article.

7

A new model of renal microvascular endothelial injury.

Nangaku M, Alpers CE, Pippin J, Shankland SJ, Adler S, Kurokawa K, Couser WG, Johnson RJ. Nangaku M, et al. Kidney Int. 1997 Jul;52(1):182-94. doi: 10.1038/ki.1997.318. Kidney Int. 1997. PMID: 9211361 Free article.

8

Cyclin kinase inhibitors are increased during experimental membranous nephropathy: potential role in limiting glomerular epithelial cell proliferation in vivo.

Shankland SJ, Floege J, Thomas SE, Nangaku M, Hugo C, Pippin J, Henne K, Hockenberry DM, Johnson RJ, Couser WG. Shankland SJ, et al. Kidney Int. 1997 Aug;52(2):404-13. doi: 10.1038/ki.1997.347. Kidney Int. 1997. PMID: 9263996 Free article.

9

Direct in vivo inhibition of the nuclear cell cycle cascade in experimental mesangial proliferative glomerulonephritis with Roscovitine, a novel cyclin-dependent kinase antagonist.

Pippin JW, Qu Q, Meijer L, Shankland SJ. Pippin JW, et al. J Clin Invest. 1997 Nov 15;100(10):2512-20. doi: 10.1172/JCI119793. J Clin Invest. 1997. PMID: 9366565 Free PMC article.

10

Renal microvascular injury induced by antibody to glomerular endothelial cells is mediated by C5b-9.

Nangaku M, Alpers CE, Pippin J, Shankland SJ, Kurokawa K, Adler S, Johnson RJ, Couser WG. Nangaku M, et al. Kidney Int. 1997 Dec;52(6):1570-8. doi: 10.1038/ki.1997.487. Kidney Int. 1997. PMID: 9407502 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

141 results

Search Page